EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Potential Anti-SARS-CoV-2 Molecular Strategies

Caterina Vicidomini, Giovanni N Roviello iD

Molecules · 2023

DOI: 10.3390/molecules28052118 ↗

Kurz gefasst

Editorial in der Zeitschrift Molecules, 2023. Verfasst von Caterina Vicidomini und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biostructures and Bioimaging, Italian National Council for Research (IBB-CNR), Area di Ricerca Site and Headquarters, Via Pietro Castell…. Hauptthemen laut MEDLINE: COVID-19, Middle East Respiratory Syndrome Coronavirus, Common Cold. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Finding effective antiviral molecular strategies was a main concern in the scientific community when the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged at the end of 2019 as an easily transmissible and potentially deadly β-coronavirus able to cause the coronavirus disease 19 (COVID-19), which famously led to one of the most worrying pandemics in recent times. Other members of this zoonotic pathogenic family were already known before 2019, but apart from the SARS-CoV, which was responsible of severe acute respiratory syndrome (SARS) pandemic in 2002/2003, and Middle East respiratory syndrome coronavirus (MERS-CoV), whose main impact on humans is geographically restricted to Middle Eastern countries, the other human β-coronaviruses known at that time were those typically associated with common cold symptoms which had not led to the development of any specific prophylactic or therapeutic measures. Although SARS-CoV-2 and its mutations are still causing illness in our communities, COVID-19 is less deadly than before and we are returning to normality. Overall, the main lesson learnt after the past few years of pandemic is that keeping our bodies healthy and immunity defenses strong using sport, nature-inspired measures, and using functional foods are powerful weapons for preventing the more severe forms of illness caused by SARS-CoV-2 and, from a more molecular perspective, that finding drugs with mechanisms of action involving biological targets conserved within the different mutations of SARS-CoV-2—and possibly within the entire family of β-coronaviruses—gives more therapeutic opportunities in the scenario of future pandemics based on these pathogens. In this regard, the main protease (Mpro), having no human homologues, offers a lower risk of off-target reactivity and represents a suitable therapeutic target in the search for efficacious, broad-spectrum anti-β-coronavirus drugs. Herein, we discuss on the above points and also report some molecular approaches presented in the past few years to counteract the effects of β-coronaviruses, with a special focus on SARS-CoV-2 but also MERS-CoV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Middle East Respiratory Syndrome CoronavirusCommon ColdHumansSARS-CoV-2Antiviral Agents

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Institute of Biostructures and Bioimaging, Italian National Council for Research (IBB-CNR), Area di Ricerca Site and Headquarters, Via Pietro Castellino 111, 80131 Naples, Italy.

ORCID-Profile: Giovanni N Roviello

Zitieren

APA

Vicidomini, C., & Roviello, G. N. (2023). Potential Anti-SARS-CoV-2 Molecular Strategies. Molecules. https://doi.org/10.3390/molecules28052118

Vancouver

Vicidomini C, Roviello GN. Potential Anti-SARS-CoV-2 Molecular Strategies. Molecules. 2023. doi:10.3390/molecules28052118

BibTeX
@article{Vicidomini2023,
  author = {Vicidomini, Caterina and Roviello, Giovanni N},
  title = {Potential Anti-SARS-CoV-2 Molecular Strategies},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28052118}
}
Kostenlos starten →